- Innovative Medicine
- Immunology
- Immunodermatology
Immunodermatology
We’ll continue to strive to meet patient needs through innovative technology and our deep disease-area expertise to provide advanced therapies for the dermatology community. Our scientists are already at the forefront of molecularly defining psoriasis at the local tissue level using gene expression analysis, as well as systemically using flow cytometry and protein profiling.
Our goal is to provide maximum levels of skin clearance to treat the full range of patients with psoriasis. We aim to identify opportunities for prevention, early interception and long-term remission of this chronic, sometimes debilitating, disease.
Disease areas
Newsroom
Featured resources
Psoriasis: More than skin deep
You are now leaving jnj.com
This link will take you to a website outside of Johnson and Johnson, which is governed by its own privacy policy and terms of use.
You are now leaving jnj.com
This link will take you to a website outside of Johnson and Johnson, which is governed by its own privacy policy and terms of use.
Sex, stigma, and satisfaction for psoriasis patients
You are now leaving jnj.com
This link will take you to a website outside of Johnson and Johnson, which is governed by its own privacy policy and terms of use.
You are now leaving jnj.com
This link will take you to a website outside of Johnson and Johnson, which is governed by its own privacy policy and terms of use.
Under the skin: Improving the “invisible” symptoms of psoriasis
You are now leaving jnj.com
This link will take you to a website outside of Johnson and Johnson, which is governed by its own privacy policy and terms of use.
You are now leaving jnj.com
This link will take you to a website outside of Johnson and Johnson, which is governed by its own privacy policy and terms of use.